epigallocatechin gallate has been researched along with Cirrhosis in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 17 (53.13) | 24.3611 |
| 2020's | 12 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Liu, G; Wang, Y | 1 |
| Li, YH; Qin, LQ; Xu, JY; Yin, XB; Yuan, L; Zhang, L | 1 |
| George, J; Tsuchishima, M; Tsutsumi, M | 1 |
| Jia, Q; Li, Y; Mehmood, S; Yang, R | 1 |
| Fang, L; Huang, J; Ou, K; Wang, C; Wang, Q; Xia, S; Zhang, S | 1 |
| Cai, Z; Dai, C; Gui, L; Hu, X; Liu, X; Qi, M; Wang, F; Yang, H | 1 |
| Chen, L; Fan, X; Song, B; Song, Y; Wang, T; Wu, J; Yang, L; Yang, Q; Yu, Z; Zhang, Z | 1 |
| Adamcakova, J; Balentova, S; Barosova, R; Hanusrichterova, J; Kalenska, D; Mikolka, P; Mokra, D; Mokry, J; Prso, K; Tatarkova, Z | 1 |
| Cai, C; Chu, T; Fang, F; Feng, S; Feng, Y; Gao, B; He, M; Liu, Y; Lu, L; Shi, R; Wang, Z; Zhang, X | 1 |
| Brennan, JT; Islam, MS; Parish, M; Segars, JH; Winer, BL | 1 |
| Kanlaya, R; Nilnumkhum, A; Peerapen, P; Plumworasawat, S; Sueksakit, K; Thongboonkerd, V | 1 |
| Chen, J; Lei, Y; Liu, J; Liu, M | 1 |
| Asenso, J; Chu, J; Fan, X; Han, Y; Li, S; Li, X; Li, Y; Peng, J; Shen, L; Wang, Q; Zhu, Y | 1 |
| Abukhalil, MH; El-Missiry, MA; El-Sawi, MR; Othman, AI | 1 |
| Chakrapani, LN; Johnson, T; Mohan, T; Periandavan, K; Singh, A; Srinivasan, AK; Velusamy, P | 1 |
| Govindaraj, S; Muhammed, I; Sankar, S | 1 |
| Chen, K; Chen, W; Han, Y; Hou, P; Huang, XY; Liu, SL; Qi, J; Wang, Y; Wu, TS; Yao, H; Yu, KF | 1 |
| Chen, J; Lei, Y; Zhou, J; Zhou, X | 1 |
| Fung, ML; Ho, CT; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J | 1 |
| Darcha, C; Matsuzaki, S | 1 |
| Bian, X; Du, F; Liu, N; Su, X; Sun, G; Wang, B; Wang, Y; Zhou, G | 1 |
| Andre, F; aus dem Siepen, F; Buss, SJ; Giannitsis, E; Katus, HA; Kristen, AV; Seitz, S; Steen, H | 1 |
| Cai, Y; Cai, YP; He, SQ; Hong, HQ; Zhang, M; Zhao, L | 1 |
| Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
| Kanlaya, R; Kapincharanon, C; Khamchun, S; Thongboonkerd, V | 1 |
| Chen, J; Du, L; Li, J; Song, H | 1 |
| Gu, ZL; Guo, CY; Sheng, R; Xie, ML; Zhou, WX | 1 |
| Li, Q; Tan, X; Wang, W; Zeng, X; Zhang, M | 1 |
| Khatwa, UU; Kleibrink, BE; Liang, OD; Mfarrej, B; Schuette-Nuetgen, K; Subramaniam, M | 1 |
| Cai, Y; Chen, TT; Gao, S; Geng, B; Liu, PQ; Ye, JT; Yu, SS; Yu, Y | 1 |
| Chen, A; Yumei, F; Zheng, S; Zhou, Y | 1 |
| Kou, Y; Li, YQ; Meng, M; Ren, HB; Yan, MX | 1 |
1 trial(s) available for epigallocatechin gallate and Cirrhosis
| Article | Year |
|---|---|
Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
Topics: Administration, Oral; Aged; Amyloid; Amyloidosis; Camellia sinensis; Capsules; Cardiomyopathies; Catechin; Contrast Media; Extracellular Matrix; Fibrosis; Gadolinium DTPA; Germany; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Myocardium; Plant Extracts; Predictive Value of Tests; Time Factors; Treatment Outcome; Ventricular Remodeling | 2015 |
31 other study(ies) available for epigallocatechin gallate and Cirrhosis
| Article | Year |
|---|---|
Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2021 |
Protective effects of epigallocatechin-3-o-gallate combined with organic selenium against transforming growth factor-beta 1-induced fibrosis in LX-2 cells.
Topics: Antioxidants; Catechin; Cell Line; Fibrosis; Humans; Selenium; Selenomethionine; Tea; Transforming Growth Factor beta1 | 2022 |
Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis.
Topics: Animals; Body Weight; Catechin; Collagen Type I; Collagen Type IV; Dimethylnitrosamine; Fibrosis; Hepatic Stellate Cells; Hyaluronic Acid; Liver; Liver Cirrhosis; Malondialdehyde; Osteopontin; Rats | 2022 |
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Beclin-1; Blood Glucose; Catechin; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Hydroxyproline; Hypertrophy; Mammals; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microtubule-Associated Proteins; Rats; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1 | 2022 |
EGCG exposure during pregnancy affects uterine histomorphology in F1 female mice and the underlying mechanisms.
Topics: Animals; Atrophy; Catechin; Female; Fibrosis; Inflammation; Mice; Mice, Inbred C57BL; Pregnancy; Tea | 2022 |
Epigallocatechin Gallate Protects Diabetes Mellitus Rats Complicated with Cardiomyopathy through TGF-β1/JNK Signaling Pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Male; MAP Kinase Signaling System; Rats; Rats, Sprague-Dawley; Streptozocin; Transforming Growth Factor beta1 | 2022 |
EGCG inhibits hypertrophic scar formation in a rabbit ear model.
Topics: Animals; Catechin; Cicatrix, Hypertrophic; Collagen; Fibrosis; Mice; Rabbits; Rats; RNA, Messenger | 2023 |
Effects of Green Tea Polyphenol Epigallocatechin-3-Gallate on Markers of Inflammation and Fibrosis in a Rat Model of Pulmonary Silicosis.
Topics: Animals; Catechin; Fibrosis; Inflammation; Lung; Polyphenols; Rats; Silicon Dioxide; Silicosis; Tea | 2023 |
Inhibition of macrophages inflammasome activation
Topics: Animals; Autophagy; Fibrosis; Hepatitis B virus; Hepatitis B, Chronic; HMGB1 Protein; Inflammasomes; Liver Cirrhosis; Macrophages; Mice | 2023 |
Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids.
Topics: beta Catenin; Catechin; Fibrosis; Humans; Leiomyoma; Proto-Oncogene Proteins c-akt; Signal Transduction | 2023 |
Epigallocatechin-3-gallate prevents TGF-β1-induced epithelial-mesenchymal transition and fibrotic changes of renal cells via GSK-3β/β-catenin/Snail1 and Nrf2 pathways.
Topics: Animals; beta Catenin; Catechin; Dogs; Epithelial-Mesenchymal Transition; Fibronectins; Fibrosis; Glycogen Synthase Kinase 3 beta; Humans; Kidney; Madin Darby Canine Kidney Cells; Microscopy, Atomic Force; NF-E2-Related Factor 2; Phosphorylation; RNA, Small Interfering; Signal Transduction; Snail Family Transcription Factors; Transforming Growth Factor beta1 | 2020 |
Potential ameliorative effects of epigallocatechin-3-gallate against cigarette smoke exposure induced renal and hepatic deficits.
Topics: Animals; Catechin; Epithelial-Mesenchymal Transition; Fibrosis; Inflammation; Kidney; Liver; Liver Cirrhosis; Male; Oxidative Stress; Rats; Tobacco Smoke Pollution; Transforming Growth Factor beta1 | 2020 |
Epigallocatechin gallate attenuates overload‑induced cardiac ECM remodeling via restoring T cell homeostasis.
Topics: Animals; Catechin; Cell Differentiation; Cytokines; Extracellular Matrix; Fibrosis; Homeostasis; Lymphocyte Activation; Male; Myocardium; Rats, Sprague-Dawley; T-Lymphocytes; T-Lymphocytes, Regulatory; Th17 Cells | 2017 |
Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Apoptosis; Biomarkers; Cardiotonic Agents; Catechin; Cytokines; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Male; Myocardium; Niacinamide; Oxidative Stress; Rats, Wistar; Risk Factors; Streptozocin | 2017 |
Impact of EGCG Supplementation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis.
Topics: Animals; Apoptosis; Catechin; Diabetic Nephropathies; Fibrosis; Humans; Kidney; Male; Prospective Studies; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2017 |
Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats.
Topics: Age Factors; Aging; Animals; Antioxidants; Apoptosis; Cardiomyopathies; Catechin; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Lipids; Myocytes, Cardiac; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
Topics: Animals; Apoptosis; Biomarkers; Catechin; Cytokines; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Male; Mice; Myocardium; Oxidative Stress; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ultrasonography | 2018 |
Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Topics: Animals; Catechin; Collagen; Epithelial-Mesenchymal Transition; Fibrosis; Male; MicroRNAs; Oxidative Stress; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Receptors, Estrogen; Smad3 Protein; Testosterone; Transforming Growth Factor beta1 | 2018 |
Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cyclooxygenase 2; Diet, High-Fat; Down-Regulation; Fatty Liver; Female; Fibrosis; Forkhead Transcription Factors; Inflammation; Liver; Matrix Metalloproteinase 2; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Tumor Necrosis Factor-alpha | 2014 |
Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
Topics: Acetylcysteine; Actins; Adult; Animals; Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Connective Tissue Growth Factor; Endometriosis; Female; Fibronectins; Fibrosis; Humans; Matrix Metalloproteinase 2; Mice; Mice, Nude; Peptide Fragments; Signal Transduction | 2014 |
Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Catechin; Cytokines; Fibrosis; Kidney; Kidney Glomerulus; Kidney Tubules; Macrophages; Male; Mice, Inbred C57BL; Organ Size; Protective Agents; Signal Transduction; Smad Proteins; Urethral Obstruction | 2015 |
High doses of (-)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice.
Topics: Administration, Oral; Animals; Catechin; Collagen; Connective Tissue Growth Factor; Fibronectins; Fibrosis; Mice; Myocardium; Tea | 2015 |
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |
Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells.
Topics: Animals; Catechin; Dogs; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney Tubules; Madin Darby Canine Kidney Cells; NF-E2-Related Factor 2; Oxalates; RNA, Small Interfering; Signal Transduction | 2016 |
Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis.
Topics: Animals; Antioxidants; Blotting, Western; Cadmium; Catechin; Fibrosis; Immunoenzyme Techniques; Male; Oxidative Stress; Rats; Rats, Wistar; Renal Insufficiency, Chronic | 2016 |
EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Cardiomegaly; Catechin; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelins; Enzyme Inhibitors; Fibroblasts; Fibrosis; Hydroxyproline; Male; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transcription Factors | 2009 |
Green tea may be benefit to the therapy of atrial fibrillation.
Topics: Animals; Antioxidants; Atrial Fibrillation; Catechin; Fibrosis; Humans; Inflammation; Myocardium; Oxidative Stress; Phytotherapy; Plant Extracts; Tea | 2011 |
Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease.
Topics: Animals; Bronchiolitis Obliterans; Catechin; Cytokines; Fibrosis; Inflammation; Lung Transplantation; Mice; Neutrophil Infiltration; Tea | 2011 |
EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast.
Topics: Animals; Catechin; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Fibroblasts; Fibronectins; Fibrosis; Gene Expression Regulation, Neoplastic; Humans; Male; Myocardium; NF-kappa B; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea | 2013 |
The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells.
Topics: Animals; Antioxidants; Catechin; Cell Culture Techniques; Cells, Cultured; Connective Tissue Growth Factor; Culture Media; Dose-Response Relationship, Drug; Extracellular Matrix; Fibrinogen; Fibrosis; Glutathione; Hepatocytes; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; Liver; Male; Procollagen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Transforming Growth Factor beta; Signal Transduction; Tea; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Effects of epigallocatechin gallate on diethyldithiocarbamate-induced pancreatic fibrosis in rats.
Topics: Actins; Administration, Oral; Animals; Catechin; Collagen; Ditiocarb; Dose-Response Relationship, Drug; Fibrosis; Histocytochemistry; Immunohistochemistry; Male; Molecular Structure; Molecular Weight; Muscle, Smooth; Pancreatic Diseases; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Smad3 Protein; Smad7 Protein; Time Factors; Transforming Growth Factor beta1 | 2007 |